JP Morgan Adds Gilead Sciences To Analyst Focus list

JP Morgan has added Overweight-rated Gilead Sciences GILD to its JP Morgan Analyst Focus List. Price target is currently set at $50.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesAnalyst RatingsBiotechnologyHealth CareJP Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!